Get In Touch with Prellis Biologics
Please tell us a little bit about yourself and why you'd like to get connected. Prellis Biologics + SOSV will follow up with you via email.
Therapeutic drug development company, created via bioprinted lymph node organoids
Prellis is leveraging their unique approach to tissue engineering to support the first use of synthetic human tissue for de novo therapeutic antibody discovery. The company’s platform allows for 3-5x more rapid development of highly specific antibodies with high affinity, generating dozens of diverse candidates for each target, at a cost to the company of an order of magnitude cheaper than prior methods.
Please tell us a little bit about yourself and why you'd like to get connected. Prellis Biologics + SOSV will follow up with you via email.
No Offer, Solicitation, Advice, or Recommendation
Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.